Changes in bone turnover markers and bone modulators during abatacept treatment

Rheumatoid arthritis (RA) causes bone loss, only partly related to inflammation. The impact of RA treatments on bone metabolism and their ability to mitigate bone loss remains uncertain. The primary goal of our study was to examine the influence of abatacept on serum levels of markers and regulators...

Descripción completa

Detalles Bibliográficos
Autores principales: Adami, Giovanni, Orsolini, Giovanni, Rossini, Maurizio, Pedrollo, Elisa, Fratucello, Anna, Fassio, Angelo, Viapiana, Ombretta, Milleri, Stefano, Fracassi, Elena, Bixio, Riccardo, Gatti, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567677/
https://www.ncbi.nlm.nih.gov/pubmed/37821541
http://dx.doi.org/10.1038/s41598-023-44374-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567677/
https://www.ncbi.nlm.nih.gov/pubmed/37821541
http://dx.doi.org/10.1038/s41598-023-44374-2

Ejemplares similares